Outlier in BE [Study As­sess­ment]

posted by ElMaestro  – Belgium?, 2018-03-18 14:43 (851 d 00:47 ago) – Posting: # 18570
Views: 3,533

Hi Gopinath,

how about auditing the study before you take any further decisions?

I am hearing you more or less say that you think the products in spite of the data are BE. That's why you want to exclude the subject in question, and that's why you think there is a grounds to believe the subject in question does not reflect the product's average performance, variance taken into consideration .

Therefore, a for-cause audit might have merit. If your audit illustrates a general issue at the CRO then that's some pretty valuable knowledge to have prior to deciding on a repeat study (and especially where it is to take place).

I could be wrong, but...

Best regards,
ElMaestro

"Pass or fail" (D. Potvin et al., 2008)

Complete thread:

Activity
 Admin contact
20,859 posts in 4,361 threads, 1,451 registered users;
online 19 (1 registered, 18 guests [including 6 identified bots]).
Forum time: 16:31 CEST (Europe/Vienna)

The interpretation of facts in a certain way
stimulates other scientists’ thoughts.    Róbert Bárány

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5